ID   CLPB_RAT                Reviewed;         677 AA.
AC   Q9WTT2;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   24-JUL-2024, entry version 142.
DE   RecName: Full=Mitochondrial disaggregase;
DE            EC=3.6.1.- {ECO:0000250|UniProtKB:Q9H078};
DE   AltName: Full=Suppressor of potassium transport defect 3;
DE   Contains:
DE     RecName: Full=Mitochondrial disaggregase, cleaved form;
DE   Flags: Precursor;
GN   Name=Clpb {ECO:0000312|RGD:621328}; Synonyms=Skd3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Testis;
RA   Hondo E.;
RT   "Molecular cloning and expression of suppressor of potassium transport
RT   defect 3 (SKD3) in rat testis.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Functions as a regulatory ATPase and participates in
CC       secretion/protein trafficking process. Has ATP-dependent protein
CC       disaggregase activity and is required to maintain the solubility of key
CC       mitochondrial proteins. Involved in mitochondrial-mediated antiviral
CC       innate immunity, activates RIG-I-mediated signal transduction and
CC       production of IFNB1 and pro-inflammatory cytokine IL6. Plays a role in
CC       granulocyte differentiation. {ECO:0000250|UniProtKB:Q9H078}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9H078};
CC   -!- ACTIVITY REGULATION: Disaggregase activity is inhibited by ADP.
CC       {ECO:0000250|UniProtKB:Q9H078}.
CC   -!- SUBUNIT: Homododecamer when substrate-bound; the homododecamer consists
CC       of 2 homohexamers stacked head-to-head via ANK repeat-mediated
CC       interactions. The active substrate-bound form is likely to exist in a
CC       dynamic equilibrium between homohexamers and homododecamers.
CC       Homotetradecamer in the unbound state which is remodeled upon substrate
CC       binding into the homododecamer. Interacts with PHB and PHB2. Interacts
CC       with MAVS; the interaction is enhanced by Sendai virus infection.
CC       {ECO:0000250|UniProtKB:Q9H078}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000250|UniProtKB:Q9H078}.
CC   -!- DOMAIN: The ankyrin-repeat region is necessary for ATP-dependent
CC       protein disaggregase activity. It plays an important role in
CC       stabilizing the substrate-bound homododecamer by mediating contacts
CC       between the two homohexamers. {ECO:0000250|UniProtKB:Q9H078}.
CC   -!- PTM: Proteolytically cleaved by protease PARL. ATP-dependent protein
CC       disaggregase activity is stimulated by PARL-mediated cleavage of the N-
CC       terminal autoinhibitory peptide. {ECO:0000250|UniProtKB:Q9H078}.
CC   -!- SIMILARITY: Belongs to the ClpA/ClpB family. {ECO:0000305}.
CC   -!- CAUTION: Despite its gene name, this protein differs in domain
CC       structure from bacterial clpB. Bacterial clpB contains two AAA modules,
CC       one in the N-terminal part of the protein and one in the C-terminal
CC       part, separated by a coiled coil, while vertebrate CLPB contains a
CC       single C-terminal AAA region and an N-terminal ANK repeat region which
CC       is absent from bacterial clpB. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB027570; BAA78095.1; -; mRNA.
DR   RefSeq; NP_075236.1; NM_022947.1.
DR   AlphaFoldDB; Q9WTT2; -.
DR   SMR; Q9WTT2; -.
DR   STRING; 10116.ENSRNOP00000072796; -.
DR   iPTMnet; Q9WTT2; -.
DR   PhosphoSitePlus; Q9WTT2; -.
DR   jPOST; Q9WTT2; -.
DR   PaxDb; 10116-ENSRNOP00000026665; -.
DR   GeneID; 65041; -.
DR   KEGG; rno:65041; -.
DR   AGR; RGD:621328; -.
DR   CTD; 81570; -.
DR   RGD; 621328; Clpb.
DR   eggNOG; KOG1051; Eukaryota.
DR   InParanoid; Q9WTT2; -.
DR   OrthoDB; 35211at2759; -.
DR   PhylomeDB; Q9WTT2; -.
DR   PRO; PR:Q9WTT2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; ISS:UniProtKB.
DR   GO; GO:0140545; F:ATP-dependent protein disaggregase activity; ISS:UniProtKB.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:RGD.
DR   GO; GO:0034605; P:cellular response to heat; ISO:RGD.
DR   GO; GO:0030851; P:granulocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0039529; P:RIG-I signaling pathway; ISO:RGD.
DR   CDD; cd19499; RecA-like_ClpB_Hsp104-like; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR019489; Clp_ATPase_C.
DR   InterPro; IPR001270; ClpA/B.
DR   InterPro; IPR050130; ClpA_ClpB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11638; ATP-DEPENDENT CLP PROTEASE; 1.
DR   PANTHER; PTHR11638:SF93; CASEINOLYTIC PEPTIDASE B PROTEIN HOMOLOG; 1.
DR   Pfam; PF07724; AAA_2; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF10431; ClpB_D2-small; 1.
DR   PRINTS; PR00300; CLPPROTEASEA.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM01086; ClpB_D2-small; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
PE   2: Evidence at transcript level;
KW   Acetylation; ANK repeat; ATP-binding; Hydrolase; Mitochondrion;
KW   Nucleotide-binding; Reference proteome; Repeat; Transit peptide.
FT   TRANSIT         1..57
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           58..677
FT                   /note="Mitochondrial disaggregase"
FT                   /id="PRO_0000191241"
FT   CHAIN           127..677
FT                   /note="Mitochondrial disaggregase, cleaved form"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT                   /id="PRO_0000458243"
FT   REPEAT          133..162
FT                   /note="ANK 1"
FT   REPEAT          166..195
FT                   /note="ANK 2"
FT   REPEAT          235..265
FT                   /note="ANK 3"
FT   REPEAT          268..297
FT                   /note="ANK 4"
FT   REGION          64..103
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          92..126
FT                   /note="Autoinhibitory"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   REGION          477..505
FT                   /note="Regulatory; slows ATPase and disaggregase
FT                   activities"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         316
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         318
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         353
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         354
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         355
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         356
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         357
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         358
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         425
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         466
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         531
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   BINDING         590
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   SITE            126..127
FT                   /note="Cleavage; by PARL"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
FT   MOD_RES         559
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H078"
SQ   SEQUENCE   677 AA;  75702 MW;  C386466154D5C739 CRC64;
     MMLSAVLRRT APAPRLFLGL IKSPSLQSRG GAYNRSVITG DRGEPQRLRT AAWVRPGASS
     VLFPGRGAAT GGRRGERTEI PYLTAASSGR GPSPEETLPG QDSWNGVPNK AGLGMWALAM
     ALVVQCYNKN PSNKDAALME AARANNVQEV RRLLSEGADV NARHKLGWTA LMVAAISHNE
     SVVQVLLAAG ADPNLGDDFS SVYKTANEQG VHSLEVLVTR EDDFNNRLNH RASFKGCTAL
     HYAVLADDYS IVKELLGGGA NPLQRNEMGH TPLDYAREGE VMKLLKTSET KYMEKQRKRE
     AEERRRFPLE QRLEQHIIGQ ESAIATVGAA IRRKENGWYD EEHPLVFLFL GSSGIGKTEL
     AKQTAKYMHK DAKKGFIRLD MSEFQERHEV AKFIGSPPGY IGHEEGGQLT KKLKQCPNAV
     VLFDEVDKAH PDVLTIMLQL FDEGRLTDGK GKTIDCKDAI FIMTSNVASD EIAQHALQLR
     QEALEMSRNR IAENLGDVQI SDKITISKNF KENMIRPILK AHFRRDEFLG RINEIVYFLP
     FCHSELIQLV NKELNFWAKR AKQRHNITLL WDREVADVLV DGYNVQYGAR SIKHEVERRV
     VNQLAAAYEQ DLLPGGCTLR ITVEDSDKQL LKSPELPSPQ AEKRPPTLRL EIIDKDSKTH
     KLDIQAPLHP EKVCYTI
//
